Zhejiang Orient Gene Biotech Co., Ltd (Orient Gene) will establish ACCUBIO.LIMITED.UK in the UK, which is intended to achieve a new leap in overseas layout.
ACCUBIO.LIMITED.UK will set up a manufacturing plant in Arroway, Scotland, dedicated to the research and development, manufacturing and sales of biomedical products including in vitro diagnostic products. The core technologies are quantum dots, fluorescence quantitative analysis, gene sequencing and nucleic acid detection, and precision medicine, which mainly produces COVID-19 antigen, antibody and nucleic acid detection reagents, various infectious disease detection reagents for respiratory and digestive and other diseases, drug detection reagents, tumor markers and gene mutation detection reagents, as well as supporting high-end detection instruments. This move will further strengthen the cooperation with UK enterprises and contribute to the local epidemic prevention and control, as well as medical and health construction in the UK. At the same time, the products will be distributed to the UK mainland, Europe, America and the rest of the world.
Recently, James, the Consul for Life and Science of the British Consulate General in Shanghai, and his entourage visited Orient Gene in the hope that Orient Gene would invest in Scotland, and said that they would provide convenience, support and assistance for Orient Gene's investment in Scotland.